Skip to article
Astra

Cardiology

Mitral Regurgitation

A decision-focused approach to confirming severity, separating primary from secondary mitral regurgitation, selecting repair versus transcatheter therapy, and identifying patients whose ventricular remodeling or heart failure burden warrants multidisciplinary valve intervention.

Clinical question: How should clinicians quantify, phenotype, and direct intervention for clinically significant primary or secondary mitral regurgitation?

First decision

Establish mechanism before assigning a treatment pathway

The first actionable distinction is primary versus secondary MR.

Use transthoracic echocardiography (TTE) to define leaflet motion, annular and subvalvular anatomy, LV size and systolic function, left atrial size, and pulmonary pressure estimates. Describe leaflet motion with the Carpentier classification because this links the observed jet to valve pathology and repair strategy. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | Heart

Classify MR as primary when the initiating lesion is within the valve apparatus, such as degenerative leaflet prolapse or flail and chordal abnormality. Classify MR as secondary when LV disease causes leaflet malcoaptation; this distinction is essential because natural history, severity interpretation, and treatment choices differ. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | Heart

Obtain transesophageal echocardiography (TEE) when TTE does not adequately define leaflet or chordal anatomy, when repairability is uncertain, or when transcatheter edge-to-edge repair (TEER) is being considered. Dedicated review of echocardiographic and cross-sectional imaging by experienced valve clinicians should precede a multidisciplinary decision on intervention. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartBMJGetting the best from the Heart Team: guidance for cardiac ...

Mechanism-based classification directs imaging interpretation and intervention planning. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartBMJGetting the best from the Heart Team: guidance for cardiac ...
MR phenotypeKey imaging findingImmediate next action
Primary MRAbnormality of the mitral valve apparatus; use Carpentier leaflet-motion classification to define mechanism. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartAssess likelihood of durable surgical repair and obtain TEE when anatomy is insufficiently defined on TTE. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartBMJGetting the best from the Heart Team: guidance for cardiac ...
Secondary MRMR arising from LV disease and leaflet malcoaptation rather than intrinsic valve disease. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartIntegrate heart failure expertise, optimize the heart failure pathway, and assess candidacy for valve intervention through a multidisciplinary team. BMJGetting the best from the Heart Team: guidance for cardiac ...Oxford AcademicThe management of secondary mitral regurgitation in patients ...
Indeterminate or discordant MRIncongruent qualitative jet findings, quantitative measures, chamber remodeling, or clinical status. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartACCClinical TrialReview image quality and use three-dimensional echocardiography or CMR when additional anatomic or volumetric clarification will alter management. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartACCClinical Trial

Quantification

Grade MR with an integrated echocardiographic assessment

Quantitative thresholds must be interpreted in the context of mechanism and jet geometry.

For severe MR, integrate vena contracta, effective regurgitant orifice area (EROA), regurgitant volume, regurgitant fraction, jet characteristics, pulmonary venous flow, and ventricular response rather than making a decision from any isolated metric. The American Society of Echocardiography threshold cited for severe MR includes vena contracta greater than 0.7 cm, regurgitant volume greater than 60 mL, and regurgitant fraction greater than 50%. AHA JournalsPercutaneous Interventions for Secondary Mitral Regurgitation

For holosystolic primary MR, EROA of at least 40 mm² and regurgitant volume of at least 60 mL are conventional severe-MR thresholds. Quantitative Doppler data likewise identified severe MR thresholds of 60 mL regurgitant volume, 50% regurgitant fraction, and 40 mm² effective orifice area. AHA JournalsGrading of Mitral Regurgitation by Quantitative Doppler ...ACCClinical Trial

Secondary MR requires special caution. An EROA of at least 20 mm² or regurgitant volume of at least 30 mL has been used as a severe-MR threshold in guideline-based frameworks, but PISA can substantially underestimate severity when the regurgitant orifice is elliptical or multiple jets are present. Consider three-dimensional EROA assessment when this limitation changes referral or procedural decisions, recognizing that three-dimensional imaging may overestimate actual EROA. ACCClinical Trial

Quantitative findings used to identify severe MR require mechanism-specific interpretation. AHA JournalsPercutaneous Interventions for Secondary Mitral RegurgitationAHA JournalsGrading of Mitral Regurgitation by Quantitative Doppler ...ACCClinical Trial
MeasureSevere primary MRSecondary-MR interpretation
Vena contractaGreater than 0.7 cm is a cited severe-MR criterion. AHA JournalsPercutaneous Interventions for Secondary Mitral RegurgitationUse within an integrated assessment; secondary MR is often geometrically complex. AHA JournalsPercutaneous Interventions for Secondary Mitral RegurgitationACCClinical Trial
EROAAt least 40 mm² for holosystolic primary MR. AHA JournalsGrading of Mitral Regurgitation by Quantitative Doppler ...ACCClinical TrialAt least 20 mm² has been used as a severe threshold; PISA may underestimate an elliptical orifice. ACCClinical Trial
Regurgitant volumeAt least 60 mL for holosystolic primary MR. AHA JournalsGrading of Mitral Regurgitation by Quantitative Doppler ...ACCClinical TrialAt least 30 mL has been used as a severe threshold; interpret with jet geometry and timing. ACCClinical Trial
Regurgitant fractionAt least 50% supports severe MR. AHA JournalsPercutaneous Interventions for Secondary Mitral RegurgitationAHA JournalsGrading of Mitral Regurgitation by Quantitative Doppler ...Use as part of an integrated assessment rather than as a stand-alone trigger. AHA JournalsPercutaneous Interventions for Secondary Mitral RegurgitationACCClinical Trial

Degenerative disease

Route primary MR to durable repair when intervention is indicated

Repairability and center expertise are decisive in degenerative MR.

For severe symptomatic MR, surgical mitral repair is the preferred therapeutic option when degenerative anatomy has a high likelihood of successful repair; valve replacement is the alternative when intervention is indicated but repair is not feasible or durable. jaccThrombotic Risk and Antithrombotic Strategies After Transcatheter Mitral Valve Replacement

Refer patients being considered for mitral intervention through a multidisciplinary valve team that identifies lesion severity, the intended intervention, and the appropriate surgeon or operator. For degenerative disease amenable to repair, use a surgeon with dedicated mitral expertise and contemporary repair outcomes; referral to another center is appropriate when local repair expertise is insufficient. BMJGetting the best from the Heart Team: guidance for cardiac ...

Use TEE-based segmental anatomy to distinguish lesions likely to support repair from those that may require replacement or transcatheter alternatives. The procedural plan should specify whether the valve is repairable before treatment selection, rather than treating all severe primary MR as interchangeable. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartBMJGetting the best from the Heart Team: guidance for cardiac ...

Intervention pathway for primary MR emphasizes anatomy and repair expertise. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartBMJGetting the best from the Heart Team: guidance for cardiac ...jaccThrombotic Risk and Antithrombotic Strategies After Transcatheter Mitral Valve Replacement
Clinical findingPreferred decisionReason for escalation
Degenerative MR with anatomy amenable to durable repairRefer for surgical mitral repair by an experienced mitral surgeon. BMJGetting the best from the Heart Team: guidance for cardiac ...jaccThrombotic Risk and Antithrombotic Strategies After Transcatheter Mitral Valve ReplacementRepair is the first-line operative option in severe symptomatic degenerative MR when success is likely. jaccThrombotic Risk and Antithrombotic Strategies After Transcatheter Mitral Valve Replacement
Intervention indicated but durable repair unlikelyConsider mitral valve replacement as the surgical alternative. jaccThrombotic Risk and Antithrombotic Strategies After Transcatheter Mitral Valve ReplacementReplacement is used when indicated intervention cannot be reliably repaired. jaccThrombotic Risk and Antithrombotic Strategies After Transcatheter Mitral Valve Replacement
Uncertain anatomy or procedural suitabilityObtain expert TEE review and multidisciplinary valve-team assessment. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartBMJGetting the best from the Heart Team: guidance for cardiac ...Leaflet and chordal definition determines repairability and treatment choice. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | Heart

Heart failure pathway

Treat secondary MR as a heart failure and valve disease problem

Secondary MR management requires heart failure optimization and anatomic selection for intervention.

Secondary MR is common, increases with age, and is associated with excess mortality. Its treatment pathway should include a heart failure specialist because the valve lesion arises in the setting of LV disease and the expected benefit of intervention depends on patient phenotype. BMJGetting the best from the Heart Team: guidance for cardiac ...BMJBurden, treatment use, and outcome of secondary mitral ...

For patients with secondary MR being considered for intervention, perform Heart Team review after defining MR mechanism and severity, reviewing TTE and any CMR or other cross-sectional imaging, and determining the planned procedure. The multidisciplinary group should function as the entry point for patients under consideration for mitral intervention. BMJGetting the best from the Heart Team: guidance for cardiac ...

TEER with MitraClip has randomized-trial evidence in selected patients with heart failure and secondary MR. COAPT was a multicenter randomized controlled trial of MitraClip in patients with heart failure and MR, and five-year follow-up reported lower rates of all hospitalizations and heart failure hospitalizations with transcatheter repair. NEJMFive-Year Follow-up after Transcatheter Repair ...NEJMTranscatheter Mitral-Valve Repair in Patients with Heart ... Divergent results between COAPT and MITRA-FR reinforce that secondary-MR phenotyping and patient selection are central rather than optional. BMJthe Gulf MTEER registry (GULF Mitral Transcatheter Edge ...Oxford AcademicThe management of secondary mitral regurgitation in patients ...Oxford AcademicRandomized controlled trials in valvular heart disease

Secondary-MR intervention decisions require integrated heart failure and valve assessment. BMJGetting the best from the Heart Team: guidance for cardiac ...BMJthe Gulf MTEER registry (GULF Mitral Transcatheter Edge ...NEJMFive-Year Follow-up after Transcatheter Repair ...NEJMTranscatheter Mitral-Valve Repair in Patients with Heart ...Oxford AcademicThe management of secondary mitral regurgitation in patients ...
Decision pointActionInterpretation
Secondary MR recognized on TTEDefine LV-related mechanism and quantify MR with an integrated study. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartACCClinical TrialSecondary MR cannot be managed as primary degenerative valve disease. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | Heart
Considering valve interventionRefer to a Heart Team that includes heart failure expertise and reviews all relevant imaging. BMJGetting the best from the Heart Team: guidance for cardiac ...The team should identify lesion severity, intervention, and operator or surgeon. BMJGetting the best from the Heart Team: guidance for cardiac ...
TEER contemplatedAssess MitraClip/TEER suitability through structured clinical and imaging selection. BMJGetting the best from the Heart Team: guidance for cardiac ...NEJMTranscatheter Mitral-Valve Repair in Patients with Heart ...Oxford AcademicThe management of secondary mitral regurgitation in patients ...COAPT supports benefit in selected patients, whereas MITRA-FR underscores that outcomes vary across phenotypes. BMJthe Gulf MTEER registry (GULF Mitral Transcatheter Edge ...NEJMFive-Year Follow-up after Transcatheter Repair ...NEJMTranscatheter Mitral-Valve Repair in Patients with Heart ...Oxford AcademicThe management of secondary mitral regurgitation in patients ...

Interpreting trial differences

MITRA-FR reported a 54.6% primary-outcome rate, including 24.3% all-cause mortality and 48.7% unplanned hospitalization, while COAPT demonstrated benefit from MitraClip-based TEER in a selected heart failure population. These trials support referral for structured selection rather than a reflex procedural approach based solely on the presence of secondary MR. BMJthe Gulf MTEER registry (GULF Mitral Transcatheter Edge ...NEJMTranscatheter Mitral-Valve Repair in Patients with Heart ...Oxford AcademicThe management of secondary mitral regurgitation in patients ...

Follow-up

Monitor ventricular response and reassess when anatomy or physiology changes

Serial imaging should detect progression before irreversible remodeling narrows treatment options.

Follow LV chamber size and function longitudinally after MR is identified, because contemporary guidance uses LV dimensions and ejection fraction as intervention triggers in asymptomatic patients. Interpret serial change with awareness that one linear measurement may miss nonuniform remodeling, particularly in primary MR. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | Heart

Use CMR or three-dimensional echocardiography selectively when TTE-derived quantification is limited by image quality, eccentric or multiple jets, or discordant ventricular remodeling. CMR offers more reproducible and accurate volumetric tracking than linear dimensions, although volumetric thresholds have not been established as guideline intervention triggers. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | Heart

Re-refer for multidisciplinary review when serial TTE shows worsening MR, evolving LV size or function, new uncertainty about repairability, or a change in candidacy for surgical or transcatheter intervention. Imaging should be available for expert review before the intervention decision is finalized. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartBMJGetting the best from the Heart Team: guidance for cardiac ...

Imaging escalation is most useful when standard TTE does not resolve a management decision. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartBMJGetting the best from the Heart Team: guidance for cardiac ...ACCClinical Trial
Problem on follow-upNext test or reviewDecision consequence
Uncertain leaflet or chordal pathologyTEE with expert valve-imaging review. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartBMJGetting the best from the Heart Team: guidance for cardiac ...Clarifies mechanism, repairability, and transcatheter feasibility. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartBMJGetting the best from the Heart Team: guidance for cardiac ...
Possible PISA underestimation in secondary MRConsider three-dimensional EROA assessment. ACCClinical TrialMay better characterize an elliptical or multiple-jet lesion, while recognizing potential overestimation. ACCClinical Trial
Need for reproducible serial chamber assessmentConsider CMR volumetric assessment. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartImproves volumetric tracking but does not replace established guideline triggers based on linear dimensions and ejection fraction. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | Heart

Common questions

When should an apparent severe MR measurement be questioned?

Question a single severe or nonsevere quantitative value when jet geometry, timing, chamber response, and clinical status are discordant. PISA may underestimate secondary MR with an elliptical orifice or multiple jets; three-dimensional imaging can help but may overestimate EROA. BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartACCClinical Trial

References

  1. Imaging assessment of mitral and aortic regurgitation: current state of the art | Heartheart.bmj.com · heart.bmj.com
  2. Getting the best from the Heart Team: guidance for cardiac ...heart.bmj.com · heart.bmj.com
  3. Secondary tricuspid valve regurgitation: a forgotten entityheart.bmj.com · heart.bmj.com
  4. Shadows and light in transcatheter mitral valve treatmentheart.bmj.com · heart.bmj.com
  5. Burden, treatment use, and outcome of secondary mitral ...www.bmj.com · www.bmj.com
  6. the Gulf MTEER registry (GULF Mitral Transcatheter Edge ...bmjopen.bmj.com · bmjopen.bmj.com
  7. Five-Year Follow-up after Transcatheter Repair ...www.nejm.org · www.nejm.org
  8. Transcatheter Mitral-Valve Repair in Patients with Heart ...www.nejm.org · www.nejm.org
  9. Percutaneous Interventions for Secondary Mitral Regurgitationwww.ahajournals.org · www.ahajournals.org
  10. Quantitation of Mitral Regurgitation | Circulationwww.ahajournals.org · www.ahajournals.org
  11. Grading of Mitral Regurgitation by Quantitative Doppler ...www.ahajournals.org · www.ahajournals.org
  12. Valvular Heart Disease in Circulation and the ...www.ahajournals.org · www.ahajournals.org
  13. Thrombotic Risk and Antithrombotic Strategies After Transcatheter Mitral Valve Replacementwww.jacc.org · www.jacc.org
  14. Functional Mitral Regurgitation and the Role of ...www.sciencedirect.com · www.sciencedirect.com
  15. Mitral valve disease—current management and future ...www.sciencedirect.com · www.sciencedirect.com
  16. ACC/AHA and ESC/EACTS Guidelines for the ...www.sciencedirect.com · www.sciencedirect.com
  17. Review Article Secondary Mitral Regurgitationwww.sciencedirect.com · www.sciencedirect.com
  18. MitraClip Versus Surgery for Secondary Mitral ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  19. European Journal of Heart Failure expert consensus ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  20. The management of secondary mitral regurgitation in patients ...academic.oup.com · academic.oup.com
  21. Randomized controlled trials in valvular heart diseaseacademic.oup.com · academic.oup.com
  22. Comparison of Meta-Analytical Estimates Between Surgical ...academic.oup.com · academic.oup.com
  23. Cardiac remodelling and clinical outcomes after mitral edge-to ...academic.oup.com · academic.oup.com
  24. Clinical Trialwww.acc.org · www.acc.org